The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

The unassuming yet popular white button mushroom has cancer-fighting abilities, according to the results of a human clinical ...

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced promising new data from its IM-PROVE I Phase 2a ...

GATC West Virginia is making progress in medical innovation at its headquarters in the WVU Innovation Corp. Their lab is up ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

Discover how global recruitment trends influence placebo response rates in Psoriatic Arthritis trials, revealing critical ...

Discover the results of a groundbreaking phase 3 trial presented at ACR 2024, showing upadacitinib's efficacy in managing ...

WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...